Association of prenatal parabens exposure with adverse pregnancy outcomes: the role of prenatal depressive symptoms
Frontiers in Public Health · 23.04.2026 · 14
DOI: 10.3389/fpubh.2026.1802833 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Public Health, online erschienen am 23.04.2026. Verfasst von Mengjun Chang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Ningxia Medical University, Yinchuan, China. Hauptthemen laut MEDLINE: Parabens, Pregnancy Outcome, Depression, Maternal Exposure. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Depression
Abstract (Originalsprache)
Background
Parabens (PBs) are common endocrine-disrupting preservatives linked to adverse pregnancy outcomes, while prenatal depressive symptoms are also prevalent and harmful. Their combined effects remain poorly understood.
Objective
To examine individual and joint associations of prenatal PBs exposure with adverse pregnancy outcomes (APOs) and to assess modification by maternal depressive symptoms.
Methods
A prospective cohort of 934 mother-infant pairs from Ningxia, China, was analyzed. Maternal serum concentrations of five PBs were measured by HPLC-MS/MS. Depressive symptoms were assessed using the Edinburgh Postnatal Depression Scale. APOs included small vulnerable newborns, macrosomia, fetal distress, and asphyxia. Logistic regression and quantile g-computation were used, with stratified and interaction analyses.
Results
In the overall cohort, propylparaben (PrP) was significantly associated with fetal distress (OR = 1.25, 95% CI: 1.05–1.49), while mixed PBs exposure increased the risk of macrosomia (OR = 1.62, 95% CI: 1.06–2.48). Quantile g-computation revealed that ethylparaben (EtP), PrP, and heptylparaben (HeP) were the primary contributors to the mixture effect on macrosomia. Maternal depressive symptoms significantly modified these associations: among women with depressive symptoms ( n = 418), PrP was associated with overall APOs (OR = 1.21, 95% CI: 1.03–1.41), and EtP was linked to small vulnerable newborns (OR = 1.20, 95% CI: 1.04–1.38). In contrast, no significant associations were observed in women without significant depressive symptoms. Interaction analyses confirmed significant effect modification by depressive symptoms for PrP ( P -int = 0.049) and EtP ( P -int = 0.024).
Conclusion
Prenatal PBs exposure is associated with increased APOs risk, particularly among women with depressive symptoms, underscoring the importance of integrating environmental and mental health considerations into prenatal care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Public Health, Ningxia Medical University, Yinchuan, China.
- Key Laboratory of Environmental Factors and Chronic Disease Control, Yinchuan, China.
- General Hospital of Ningxia Medical University, Yinchuan, China.
Zitieren
APA
Chang, M., Li, X., Li, Y., Lv, Y., Ji, J., Liu, C., Du, Y., Ma, S., & Guan, S. (2026). Association of prenatal parabens exposure with adverse pregnancy outcomes: the role of prenatal depressive symptoms. Frontiers in Public Health, 14. https://doi.org/10.3389/fpubh.2026.1802833
Vancouver
Chang M, Li X, Li Y, Lv Y, Ji J, Liu C, et al. Association of prenatal parabens exposure with adverse pregnancy outcomes: the role of prenatal depressive symptoms. Frontiers in Public Health. 2026;14. doi:10.3389/fpubh.2026.1802833
BibTeX
@article{Chang2026,
author = {Chang, Mengjun and Li, Xianjia and Li, Ye and Lv, Yueyi and Ji, Jin and Liu, Can and Du, Yunyun and Ma, Shuqin and Guan, Suzhen},
title = {Association of prenatal parabens exposure with adverse pregnancy outcomes: the role of prenatal depressive symptoms},
journal = {Frontiers in Public Health},
year = {2026},
volume = {14},
doi = {10.3389/fpubh.2026.1802833}
}
EUVIMED